At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
Neuro-typical controls and ADHD will receive EVO game play.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
In Brief
A clinical study evaluating Neuro-typical controls and ADHD will receive EVO game play. for Attention Deficit Hyperactivity Disorder. Completed, enrolled 84 participants across 2 sites.
Detailed Summary
A study in ADHD and neuro-typical children to assess EVO game play over 29 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAttention Deficit Hyperactivity Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedSep 2013
Primary CompletionMay 2015
TodayJul 2026
First PostedSep 17, 2013
Enrollment StartSep 1, 2013
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 12.8 years ago
Interventions
Neuro-typical controls and ADHD will receive EVO game play.device
EVO mobile video application